EGFR and breast cancer: SGCE loss increases degradation of epidermal growth factor receptor (EGFR) through enhanced interaction between EGFR and its ubiquitination ligase c‐Cbl, providing a potential mechanism for understanding the failure of EGFR‐targeted treatment in breast cancer.